Dr Reddys Shares Fall As US FDA Makes 13 Observations

Posted By:
Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares in Dr Reddys Fell after the US FDA issued Form-483 with 13 observations for the company's Visakhapatnam plant.

    Dr Reddys Shares Fall As US FDA Makes 13 Observations
    "The audit of our formulation manufacturing plant at Duvvada, Visakhapatnam, by the USFDA, has been completed today (8 March, 2017). We have been issued a Form-483 with 13 observations, which we are addressing," the company said.

    The US FDA issues a Form-483 if finds any conditions that in their judgment may constitute violations of the US Food Drug and Cosmetic (FD&C) Act and related laws. This also means that the company cannot file for future product findings, unless the issues are rectified. 

    Indian pharma companies have increasingly begun being in the spotlight with some getting observations, while others get warning letters and some have already received import alert bans.

    The new US administration under US President Donald Trump has also been determined to reduce drug costs in the country.

    Check stock quote of Dr Reddys here

    Read more about: reddys
    Story first published: Thursday, March 9, 2017, 10:06 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more